PB2349: A PHASE 1, OPEN‐LABEL, MULTICENTER, DOSE‐ESCALATION STUDY OF SGR‐1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B‐CELL MALIGNANCIES

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 7; no. S3; pp. e40906a2 - n/a
Main Authors Olszewski, Adam, Kahn, David, Yoo, Brian, Nie, Zhe, Krilov, Goran, Tan, Joanne, Wright, Hamish, Weiss, Daniel, Yin, Wu, Akinsanya, Karen
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 08.08.2023
Wiley
Subjects
Publication Only
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000976116.40906.a2